
America's Social Security Crisis
Host:
- Making News: Washington State's Never-Ending Gubernatorial Recount
Six weeks after Election Day, the dead heat for Governor of the State of Washington may be broken. Trailing by only 261 votes, out of 2.9 million cast, Democrat Christine Gregoire had demanded a recount, which left her only 42 votes behind GOP candidate Dino Rossi. Late yesterday, Gregoire took the lead for the first time, by the incredibly thin margin of 8 votes. David Postman has been following the story for the Seattle Times. - Reporter's Notebook: FDA Approves Macugen for Age-Related Vision Loss
Relief is on the way for Americans who suffer from "age-related macular degeneration," an aging process that can cause blindness. Although last week's Celebrex headlines overshadowed the news, the Food and Drug Administration Friday approved a new drug that has been proven to slow vision loss. Steven Schwartz of UCLA's Jules Stein Eye Institute sits on the Scientific Advisory Board of Eyetech Pharmaceuticals, the company that developed Macugen.
Guest host Diana Nyad holds the world record for the longest swim without the aid of a cage -- from Bimini to Florida, 102.5 miles! She was inducted into the International Swimming Hall of Fame in 2002. A business sports columnist for Marketplace, Nyad has served as senior sports correspondent for Fox News, and hosted her own show on CNBC. She's also the author of three books, Other Shores, Basic Training and The Keyshawn Johnson Story. Washington State Democrats on gubernatorial recount
Washington State Supreme Court to hear gubernatorial appeal
King County Elections Division on manual recount of disputed absentee gubernatorial ballots
Seattle Times article updating the Washington gubernatorial race
Social Security Administration (SSA)
President Bush on Social Security reform
Social Security Protection Act of 2004 (HR 743)
Eyetech Pharmaceuticals on Macugen
Engage & Discuss
Further the conversation with your thoughts and comments. Agree, disagree, present a different perspective -- engage.
For information and guidelines click: Terms of Service | Privacy Policy
Please note, comments are moderated. KCRW reserves the right to edit and or remove posts deemed off-topic, abusive or not in accordance with KCRW's Privacy Policy and Terms of Use.
KCRW.com thanks our sponsor: